RTCure (@RTCure_eu) header
RTCure (@RTCure_eu) profile picture

RTCure - Rheuma Tolerance for Cure is an EU/IMI2-funded research project aiming to develop new therapies for rheumatoid arthritis by inducing immune tolerance.

Europe
Joined February 2015
Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)Photo by RTCure (@RTCure_eu)
🤔If #arthritis was detected earlier, could it be prevented? The @RTCure_eu project sought to understand just that! Join us on 5 June at 11:00 for 'In conversation with RT Cure' where we'll find out about their work on #ArthritisResearch. Register here: europa.eu/!bxTW9M
1
6
296
Preferences for preventive treatments for #rheumatoidarthritis: discrete choice survey in the UK, Germany and Romania 👇 doi.org/10.1093/rheumatology…
1
4
214
We are pleased to invite you to the 5th Digital rheumatology day. Register today! digitalrheumatology.org/5th-…
4
14
1,803
NEW PAPER: What risk of side effects is acceptable for a reduced risk of developing rheumatoid arthritis? Informing patient-focussed drug development rmdopen.bmj.com/cgi/content/… @IMI_PREFER @RRG_Birmingham @InflamAge_UoB @NIHRBhamBRC @BHPComms @unibirm_MDS
7
1
12
Apply now for the "Digital Rheumatology Research Award"! Please find further information on how to apply here: lnkd.in/eG8em44b #RheumaAward #DigitalRheumatology
3
10
🔔State-of-the-Art Keynote Speaker Meet Dr. @ProfJohnIsaacs, our State-of-the-Art keynote speaker at the 2023 Annual Scientific Meeting! He will be delivering a keynote presentation on Precision Medicine in Rheumatoid Arthritis. Register today🔗asm.rheum.ca
7
13
Interesting genetic analysis by Rachel Knevel on drug-free remission from @RTCure_eu #TTW2022 A smoking gun analysis implicates the fibroblast?
2
4
Great Pleasure to present my PhD project to partners from industry & academia @RTCure_eu Annual Meeting 2022 in Amsterdam.
1
1
3
Great presentations this afternoon on early trials in ACPA positive and the progression to RA @MRGNewcastle @Racegbn @RTCure_eu
1
3
8
A landmark paper. RA-MAP Scientific Data - the most complete immunological profile in early rheumatoid arthritis to date @RTCure_eu @Racegbn @ProfJohnIsaacs @thebarneslab @imidbio nature.com/articles/s41597-0…
7
1
12
Accelerating diagnosis in #rheumatology using #ehealth📲🚀😀 Great #teamwork @ArndKlyr @Dr_David_Simon led by @RachelKnevel supported by @EITHealth frontiersin.org/articles/10.… @digital_rheuma @medizin_digital
9
15
Want to know more about quantitative preference studies of treatments for #RheumatoidArthritis among #patients and at-risk populations? @IMI_PREFER published a #SystematicReview! #RA @reumatiker @R2P2_UoB @InflamAge_UoB 👇 bit.ly/3F3InIC
1
2
At #BSR22 3pm you may like to attend the 'Prediction and prevention of rheumatoid arthritis: an update' session chaired by RACE's Karim Raza with talks from John Isaacs and Marie Falahee amongst others (venue Boisdale) @ProfJohnIsaacs @DrMarieFalahee @MRGNewcastle @RRG_Birmingham
6
7
Increasingly more programs for individuals #at-risk for #rheumatoid #arthritis exist across Europe. With @RTCure_eu we have built the framework for researching together by setting up the #European Risk RA registry tinyurl.com/2n3nc88e 🎞️a summary: bpno.dk/gp/MjA2MTThg_Bgp0A
3
4
Join our event either virtually or on site in Berlin from May 6-7 and explore the future in Rheumatology! Register today: digitalrheumatology.org/4th-… #DigitalRheumatologyDay @LatikaGupta_ @JK77775 @KruscheMartin @ThomasHugle @Dr_David_Simon
10
16
JUST PUBLISHED! A systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations! doi.org/10.1186/s13075-021-0… @ArthritisRes
What aspects of treatments to prevent RA matter most to those at risk? More studies of people's preferences are needed to guide the development of acceptable interventions! @IMI_PREFER @RRG_Birmingham @NIHRBhamBRC @BHPComms @Racegbn rdcu.be/cHyQE
4
9